Subcutaneous Low Doses of Recombinant Human Erythropoietin in Predialysis Patients Do Not Interfere with the Progression of Renal Failure
作者:
Vincenzo Savica,
Giuseppe Costantino,
Paolo Monardo,
Guido Bellinghieri,
期刊:
American Journal of Nephrology
(Karger Available online 1995)
卷期:
Volume 15,
issue 1
页码: 10-14
ISSN:0250-8095
年代: 1995
DOI:10.1159/000168795
出版商: S. Karger AG
关键词: Erythropoietin;Renal failure;Predialysis patients
数据来源: Karger
摘要:
This paper reports a study on the treatment of predialysis patients with recombinant human erythropoietin (r-HuEPO). The haematocrit, haemoglobin, reticulocyte and platelet values as well as creatinine and creatinine clearance evaluated by standard and radio-isotopic methods before, during and after r-HuEPO treatment were determined. The slope of the inverse creatinine versus time curves was studied too. The authors did not observe any variation of the renal function parameters during and after study and suggest their protocol of r-HuEPO administration for predialysis patients.
点击下载:
PDF
(810KB)
返 回